Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Glucose control in severely burned patients: a prospective randomized trial

FY 2015-16

Summary
A burn injury represents one of the most severe forms of trauma and each year in North America, more than two million people are burned. In fact, burn injuries are second to motor vehicle accidents as the leading cause of accidental death in North America. Recent evidence indicates that hypermetabolism, a hallmark of severely burned patients, is a major contributor to these detrimental outcomes. In fact burn injury produces a profound hypermetabolic stress response that is characterized by markedly increased glucose production, lipolysis, and protein catabolism. The rationale of this prospective randomized control trial (RCT) in severely burned patients is to address the fundamental questions whether metformin can be used as a glucose controlling agent during the acute phase of severely burned patients and whether improved outcomes of burn patients with glucose control are due to insulin-specific effects. In a recent RCT we showed that insulin administration improved post-burn infections, and severity of sepsis and morbidity. However, we also found recently that insulin therapy causes a 4-5 fold increase in hypoglycemia which is associated with a 9-fold increase in mortality. Therefore insulin is a doubled edged sword, on one hand beneficial but on the other hand detrimental when hypoglycemia occurs. Therefore, it would be ideal to achieve tight glucose control but without the adverse events of hypoglycemia. Metformin appears to be such an agent to control hyperglycemia safely and effectively. Utilizing a mix of basic and clinical techniques I will answer fundamental questions and mechanisms by which insulin and or metformin improve outcomes of burn and critically ill patients. The results of this study will have direct clinical implications because they could be directly applied to improve the morbidity and life quality of severely burned patients.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
339613
Name
Abdullahi Abdikarim
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Glucose control in severely burned patients: a prospective randomized trial
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Burns; Critically Ill; Diabetes; Er Stress; Hypermetabolism; Inflammation; Insulin; Insulin Resistance; Metforim; Trauma
Abstract
A burn injury represents one of the most severe forms of trauma and each year in North America, more than two million people are burned. In fact, burn injuries are second to motor vehicle accidents as the leading cause of accidental death in North America. Recent evidence indicates that hypermetabolism, a hallmark of severely burned patients, is a major contributor to these detrimental outcomes. In fact burn injury produces a profound hypermetabolic stress response that is characterized by markedly increased glucose production, lipolysis, and protein catabolism. The rationale of this prospective randomized control trial (RCT) in severely burned patients is to address the fundamental questions whether metformin can be used as a glucose controlling agent during the acute phase of severely burned patients and whether improved outcomes of burn patients with glucose control are due to insulin-specific effects. In a recent RCT we showed that insulin administration improved post-burn infections, and severity of sepsis and morbidity. However, we also found recently that insulin therapy causes a 4-5 fold increase in hypoglycemia which is associated with a 9-fold increase in mortality. Therefore insulin is a doubled edged sword, on one hand beneficial but on the other hand detrimental when hypoglycemia occurs. Therefore, it would be ideal to achieve tight glucose control but without the adverse events of hypoglycemia. Metformin appears to be such an agent to control hyperglycemia safely and effectively. Utilizing a mix of basic and clinical techniques I will answer fundamental questions and mechanisms by which insulin and or metformin improve outcomes of burn and critically ill patients. The results of this study will have direct clinical implications because they could be directly applied to improve the morbidity and life quality of severely burned patients.
Competitiondate
201511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Abdullahi, Abdikarim
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
University of Toronto - $150,000 Grant (2015-16) | Canada Spends